Tenderwize
Retour à la recherche

Lotto 1

PuntoZero s.c.a.r.l.·Perugia, Italy·EUR 3500M·Deadline Oct 01, 2029 · 1136 days left·Restricted·Supplies·DPS
Inscrivez-vous pour sauvegarderOpen documents
High valueStructured notice only
Titre original de l'avis

Italy – Pharmaceutical products – Bando SDA FARMACI EMODERIVATI SOLUZIONI INFUSIONALI VACCINI E MEZZI DI CONTRASTO prima edizione

70/100

Score d'opportunité

PromisingMedium complexity
SuppliesDPSOpen
Pourquoi ce score ?

Opportunité

70 / 100

Complexité

65 / 100

Facteurs de risque

Restricted procedure means only pre-qualified suppliers can bid on specific contracts; initial qualification may be com...

Procurement documents are available but were not analyzed; there may be hidden requirements.

Restricted procedure — pre-qualification required

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Strong opportunity

Faits clés

  • EUR 3500M estimated value
  • Dynamic Purchasing System (DPS)
  • Supplies contract
  • 1 lot
  • Duration 1460 DAY
  • Supply of pharmaceutical products (blood-derived drugs, infusion solutions, vaccines, contrast media)
  • DPS covering a period of 1460 days (approx. 4 years)
Afficher le résumé complet

This tender is a Dynamic Purchasing System (DPS) for pharmaceutical products (blood-derived drugs, infusion solutions, vaccines, and contrast media) issued by PuntoZero s.c.a.r.l. on behalf of Italian healthcare entities. It is a restricted procedure with a single lot, valued at €3.5 billion, covering a 4-year period. The award is based solely on price. The tender is published in Italian, with submission required electronically via the provided platform. The deadline for submission is October 1, 2029. Key eligibility includes registration with professional/commercial registers and certifications for quality and environmental management.

Risques

Restricted procedure means only pre-qualified suppliers can bid on specific contracts; initial qualification may be com...

Procurement documents are available but were not analyzed; there may be hidden requirements.

Restricted procedure — pre-qualification required

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Restricted procedure – only pre-selected suppliers may bid on specific contracts

Administrative

  • DPS participation requires registration on the platform (Aura)
  • Submission must be electronic via Ouvrir le portail

Les exigences peuvent être incomplètes.

Critères d'attribution

Lot 1

Prezzo

Acheteur

Localisation

Perugia, ITA

Profil acheteur

Ouvrir le profil

Identifiant

02915750547

Activité

General public services

Lots (1)

LOT-0001

Lotto 1

Procurement of pharmaceutical products including blood-derived drugs, infusion solutions, vaccines, and contrast media.

SuppliesDPSEU fundedElectronic submission

EUR 3.5B

Valeur estimée

Localisation

ITI21, Italy

Durée

1460 DAY

Catégorie

Pharmaceutical products

Critères d'attribution

Prezzo

Date limite

Deadline Oct 01, 2029

Détails de la procédure

Date de publication
29 Sep 2025
Langues
Italian

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
636806-2025

Documents (2)

Document de consultation 1Portail de soumission 1

Appels d'offres similaires

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3